Title
Effect of a web-based relapse prevention program on abstinence among Japanese drug users: A pilot randomized controlled trial
Date Issued
01 April 2020
Access level
metadata only access
Resource Type
journal article
Author(s)
Takano A.
Miyamoto Y.
Shinozaki T.
Matsumoto T.
Kawakami N.
Publisher(s)
Elsevier Inc.
Abstract
Background: Internet-based intervention could help drug users recover from drug dependence. This study evaluated the effectiveness of a newly developed web-based relapse prevention program (e-SMARPP) for people with a drug problem, including the use of methamphetamine, in Japan. Methods: The study was a pilot randomized controlled trial comprised of 48 psychiatric outpatients diagnosed with drug use disorder. The participants were randomly assigned to an eight-week, six-session web-based relapse prevention program (an intervention group) or only web-based self-monitoring (a control group). The primary outcome was the duration of abstinence from a primary drug during the intervention and relapse risk. Secondary outcomes included motivation to change, self-efficacy, and money spent on drugs. The outcomes, except for the duration of abstinence during the intervention, were assessed at baseline, 2-, 5-, and 8-months. Program completion rate was also assessed. Results: No significant difference was observed between the intervention and the control groups for the primary and the secondary outcomes. The effect size of the duration of abstinence during the intervention was d = 0.42, which was comparable to previous studies. In the intervention group, about 26% did not complete the entire intervention. Conclusions: e-SMARPP failed to demonstrate efficacy, however, is potentially helpful for enhancing abstinence. The low attrition rate may suggest the acceptance and feasibility of the program. Further improvement of the program and evaluation in a full-scale trial are needed.
Start page
37
End page
46
Volume
111
Language
English
OCDE Knowledge area
Farmacología, Farmacia
Toxicología
Psiquiatría
Subjects
Scopus EID
2-s2.0-85077748007
PubMed ID
Source
Journal of Substance Abuse Treatment
ISSN of the container
07405472
Sponsor(s)
We would like to acknowledge Dr. Nobuya Naruse, Dr. Ohoji Kobayashi, Dr. Nozomu Hashimoto, Dr. Takashi Sunami, Dr. Satoshi Sakakibara, Dr. Arisa Kadowaki, Dr. Sachiko Yamada, and Dr. Asuka Hida, for helping us to recruit patients for this study. The study was supported by the Pfizer Research Foundation (Japan) and \Japan Society for the Promotion of Science KAKENHI Grant Number JP16K20813. None.
Sources of information:
Directorio de Producción Científica
Scopus